Network meta-analysis of 17 RCTs (1760 patients) with MDR Gram-negative infections: beta-lactam/beta-lactamase inhibitor therapy was associated with lower all-cause mortality than colistin monotherapy (RR 0.62, 95% CI 0.39-0.99), on very low certainty evidence.
Meta-analysisn = 1,760
Rayanakorn et al. Comparative efficacy and safety of colistin-based and alternative antibiotic regimens for multidrug-resistant Gram-negative infections: A systematic review and network meta-analysis